Details of the Drug
General Information of Drug (ID: DM7KDQV)
| Drug Name |
2-Hex-5-enyl-5-non-8-enyl-pyrrolidine
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
2-Hex-5-enyl-5-non-8-enyl-pyrrolidine; CHEMBL14599; 2-(5-Hexenyl)-5-(8-nonenyl)pyrrolidine; 100594-86-3; 2-Hex-5-enyl-5-non-8-enylpyr; ACMC-20m3ob; Pyrrolidine, 2-(5-hexenyl)-5-(8-nonenyl)-; CTK0I4208; YCQNSAJAZIVRFR-UHFFFAOYSA-N; AC1L4819; BDBM50284428
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 2 | Molecular Weight (mw) | 277.5 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 6.8 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 13 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 1 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||
|
||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||


